Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition

被引：0
|
作者：
Amy D Guertin
Melissa M Martin
Brian Roberts
Melissa Hurd
Xianlu Qu
Nathan R Miselis
Yaping Liu
Jing Li
Igor Feldman
Yair Benita
Andrew Bloecher
Carlo Toniatti
Stuart D Shumway
机构：
[1] Merck Research Laboratories,Department of Oncology
[2] Amgen,Department of In Vivo Pharmacology
[3] Hudson Alpha Institute,Molecular Biomarkers
[4] Merck Research Laboratories,Screening and Protein Sciences
[5] Merck Research Laboratories,Informatics and Analysis
[6] Merck Research Laboratories,undefined
[7] Merck Research Laboratories,undefined
[8] Institute for Applied Cancer Science,undefined
来源：
Cancer Cell International | / 12卷
关键词：
LoVo Cell; Sensitive Cell Line; Checkpoint Kinase; CHK1 Inhibitor; CHK1 Kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition
    Guertin, Amy D.
    Martin, Melissa M.
    Roberts, Brian
    Hurd, Melissa
    Qu, Xianlu
    Miselis, Nathan R.
    Liu, Yaping
    Li, Jing
    Feldman, Igor
    Benita, Yair
    Bloecher, Andrew
    Toniatti, Carlo
    Shumway, Stuart D.
    CANCER CELL INTERNATIONAL, 2012, 12
  • [2] Combined inhibition of Chk1 and Wee1 In vitro synergistic effect translates to tumor growth inhibition in vivo
    Carrassa, Laura
    Chila, Rosaria
    Lupi, Monica
    Ricci, Francesca
    Celenza, Cinzia
    Mazzoletti, Marco
    Broggini, Massimo
    Damia, Giovanna
    CELL CYCLE, 2012, 11 (13) : 2507 - 2517
  • [3] CASC-578, a novel Chk1 inhibitor, is active as a single agent in solid tumors and displays synergistic anti-tumor activity in combination with Wee1 inhibition
    Vo, Alex
    Taylor, Janelle
    Rosler, Robert
    Piasecki, Julia
    Leviten, Dina
    Sierra, Teresa
    Dozier, Ashley
    Klucher, Kevin
    Boyle, Bob
    Boyce, Rich
    Peterson, Scott
    CANCER RESEARCH, 2017, 77
  • [4] Combined inhibition of Chk1 and Wee1 kinases for cancer treatment
    Hauge, S.
    Hasvold, G.
    Joel, M.
    Naucke, C.
    Rodland, G. E.
    Syljuasen, R. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S478 - S478
  • [5] Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
    Davies, Kurtis D.
    Cable, P. LouAnn
    Garrus, Jennifer E.
    Sullivan, Francis X.
    von Carlowitz, Ira
    Le Huerou, Yvan
    Wallace, Eli
    Woessner, Richard D.
    Gross, Stefan
    CANCER BIOLOGY & THERAPY, 2011, 12 (09) : 788 - 796
  • [6] Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
    Bruyer, Angelique
    Dutrieux, Laure
    de Boussac, Hugues
    Martin, Thibaut
    Chemlal, Djamila
    Robert, Nicolas
    Requirand, Guilhem
    Cartron, Guillaume
    Vincent, Laure
    Herbaux, Charles
    Lutzmann, Malik
    Bret, Caroline
    Pasero, Philippe
    Moreaux, Jerome
    Ovejero, Sara
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Chk1 inhibition and Wee1 inhibition combine synergistically to inhibit cellular proliferation
    Davies, Kurtis D.
    Sullivan, Francis
    von Carlowitz, Ira
    Le Huerou, Yvan
    Wallace, Eli
    Woessner, Richard D.
    Gross, Stefan
    CANCER RESEARCH, 2011, 71
  • [8] Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
    Di Rora, Andrea Ghelli Luserna
    Bocconcelli, Matteo
    Ferrari, Anna
    Terragna, Carolina
    Bruno, Samantha
    Imbrogno, Enrica
    Beeharry, Neil
    Robustelli, Valentina
    Ghetti, Martina
    Napolitano, Roberta
    Chirumbolo, Gabriella
    Marconi, Giovanni
    Papayannidis, Cristina
    Paolini, Stefania
    Sartor, Chiara
    Simonetti, Giorgia
    Yen, Timothy J.
    Martinelli, Giovanni
    CANCERS, 2019, 11 (11)
  • [9] Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress
    Saini, Priyanka
    Li, Yizhu
    Dobbelstein, Matthias
    ONCOTARGET, 2015, 6 (15) : 13072 - 13087
  • [10] Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma
    Carrassa, Laura
    Chila, Rosaria
    Basana, Alessandra
    Ricci, Francesca
    Guffanti, Federica
    Lupi, Monica
    Rinaldi, Andrea
    Cascione, Luciano
    Bertoni, Francesco
    Broggini, Massimo
    Damia, Giovanna
    CANCER RESEARCH, 2014, 74 (19)
12345